Idera preclinical data

In mice, subcutaneous administration of Idera's gene-silencing oligonucleotide (GSO) targeting proprotein convertase subtilisin/kexin type 9 (PCSK9) reduced total serum cholesterol and LDL-C. GSOs ar...